Better Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Better Therapeutics

08/08/2023 03:04

* Better Therapeutics Inc  BTTX.OQ   BTTX.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 9. 
    * 
    * ​Refinitiv's mean analyst estimate for Better Therapeutics
Inc
is for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $7​, above​ its last closing price of $0.71.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.36       -0.74      -0.39     Beat    47.7
 Dec. 31 2023              -0.51      -0.37     Beat    27
 Sep. 30 2022  -0.44       -0.48      -0.48     Met     -0.7​
 Jun. 30 2022  -0.46       -0.45      -0.42     Beat    6.7
 ​​Mar.        -0.40       -0.38      -0.41     Missed  -6.5
 31 2022                                                
 Dec. 31 2021  -0.47       -0.46      -0.71     Missed  -55.5​
 Sep. 30 2021  -1.66       -1.66      -0.03     Beat    98.2
 This summary was machine generated August 8 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated